The rising adoption of AI is also helping cybersecurity providers increase their marketable base in the country.

Thank you for standing by for RLX Technology Inc.'s third-quarter 2024 earnings conference call. (Operator Instructions) Today's conference call is being recorded and is expected to last for about 40 ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.